Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 6-MTH group results

Nov 12 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to  
                Sep 30, 2021        Sep 30, 2020      Mar 31, 2022 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            989 mln             614 mln            2.11     
                 (+60.8 pct)         (+8.9 pct)       (+63.8 pct)  
  Operating     loss 359 mln        loss 502 mln      loss 377 mln 
  Recurring     loss 201 mln        loss 365 mln      loss 157 mln 
  Net           loss 201 mln        loss 365 mln      loss 157 mln 
  EPS           loss 2.79 yen       loss 5.13 yen    loss 2.20 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news